Zoetis

[5] Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

[10] In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.

[15] The sell-off of Zoetis was consistent with Pfizer's recent decision to shed other non-pharmaceutical subsidiaries in an effort to save costs, raise capital, and pay off debt.

The company announced that JPMorgan Chase, Bank of America, Merrill Lynch, Goldman Sachs & Co., and Morgan Stanley would be the lead underwriters.

[22][3] Stock investors were attracted to the steep profit margin in proportion to revenue and consumer confidence in potential future growth of the subsidiary.

[29] In September 2023, Zoetis acquired Petmedix, a privately held Cambridge, UK-based company, to bring the benefits of species-specific antibody therapies to pet owners.

[30][31] Twenty-eight sites in 11 countries make up Zoetis' manufacturing network, each facility designed to meet chemical and infectious agent safety regulatory requirements.

[38] The grants have been allocated towards causes including advancing opportunities for veterinary professionals[39][40][41] and farmers,[42] providing support to those affected by the Russian invasion of Ukraine, matching gifts programs, and delivering relief to those impacted by the earthquake in the Republic of Türkiye.

Zoetis building in Exton, PA